Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Docetaxel and Cisplatin in HNSCC
NCT00623558Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Apr 2008
- Primary completion
- Nov 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in head and neck squamous cell carcinoma (HNSCC), sponsored by Seoul National University Hospital. Started Apr 2008; status: completed.
02
Drugs
cetuximab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00623558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00623558.